Cite

HARVARD Citation

    Gerstner, E. et al. (n.d.). A phase I study of cediranib in combination with cilengitide in patients with recurrent glioblastoma. Neuro-oncology. 17 (10), pp. 1386-1392. [Online]. 
  
Back to record